G812-2186 Screening compound: 1-(4-BENZYLPIPERAZIN-1-YL)-4-{3-[(4-FLUOROPHENYL)METHYL]-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL}BUTAN-1-ONE

G812-2186 Screening compound: 1-(4-BENZYLPIPERAZIN-1-YL)-4-{3-[(4-FLUOROPHENYL)METHYL]-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL}BUTAN-1-ONE
G812-2186 Screening compound: 1-(4-BENZYLPIPERAZIN-1-YL)-4-{3-[(4-FLUOROPHENYL)METHYL]-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL}BUTAN-1-ONE alternative view

Chemical Structure Depiction of ChemDiv screening compound G812-2186
1-(4-BENZYLPIPERAZIN-1-YL)-4-{3-[(4-FLUOROPHENYL)METHYL]-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL}BUTAN-1-ONE

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G812-2186

Molecular Formula

C28H30FN5O (C28 H30 FN5 O)

Compound Name

1-(4-BENZYLPIPERAZIN-1-YL)-4-{3-[(4-FLUOROPHENYL)METHYL]-3H-IMIDAZO[4,5-B]PYRIDIN-2-YL}BUTAN-1-ONE

IUPAC name

n/a

SMILES

O=C(CCCc1nc2cccnc2n1Cc(cc1)ccc1F)N1CCN(Cc2ccccc2)CC1

InChI

InChI=1S/C28H30FN5O/c29-24-13-11-23(12-14-24)21-34-26(31-25-8-5-15-30-28(25)34)9-4-10-27(35)33-18-16-32(17-19-33)20-22-6-2-1-3-7-22/h1-3,5-8,11-15H,4,9-10,16-21H2

InChI Key

ILADJBUYYVDTLH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27162994

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

471.58

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

3.540

Distribution Coefficient, logD

3.507

Water Solubility, LogSw

-3.50

Polar Surface Area

40.711

Acid Dissociation Constant (pKa)

19.02

Base Dissociation Constant (pKb)

6.30

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

32.10

G812-2186 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

GPCR Targeted Library (31838 compounds)

PI3K-Targeted Library (17255 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Targeted Diversity Library (40567 compounds)

Epigenetics Focused Set (26518 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Musculoskeletal
  • Respiratory tract
  • Nervous system
  • Congenital
  • Skin
  • Metabolic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • GPCR
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with G812-2186 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G812-2186?
Check Price and Availability of G812-2186, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G812-2186 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G812-2186
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G812-2186
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G812-2186 available by request